Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01411852 · ClinicalTrials.gov registry record · Phase 2
Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 192
- Enrollment target
NCT01411852 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 192 participants.
The verdict
NCT01411852, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 192 participants
- Enrollment target
Study Summary
Primary Aim: To determine the feasibility and safety of hypotensive resuscitation for the early treatment of patients with traumatic shock compared to standard fluid resuscitation. Primary Hypotheses: The null hypothesis regarding feasibility is that hypotensive resuscitation will result in the same volume of early crystalloid (normal saline) fluid administration compared to standard crystalloid resuscitation. The null hypothesis regarding safety is that hypotensive resuscitation will result in the same percent of patients surviving to 24 hours after 911 call received at dispatch compared to standard fluid resuscitation. Early resuscitation is defined as all fluid given until 2 hours after arrival in the Emergency Department or until hemorrhage control is achieved in the hospital, whichever occurs earlier.
Interventions
- DRUG 0.9% Sodium Chloride 250 mL bolus
- DRUG 0.9% Sodium Chloride 2000 mL bolus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01411852
The ClinicalTrials.gov registry entry for NCT01411852 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 0.9% Sodium Chloride 250 mL bolus is the first listed.
NCT01411852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01411852 about?
NCT01411852 is a clinical study titled "Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma". Primary Aim: To determine the feasibility and safety of hypotensive resuscitation for the early treatment of patients with traumatic shock compared to standard fluid resuscitation. Primary Hypotheses: The null hypothesis regarding feasibility is that hypotensive resuscitation will result in the sam...
What is the current status of trial NCT01411852?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 192 participants. The study started on 2012-03. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01411852?
The interventions under investigation include: 0.9% Sodium Chloride 250 mL bolus (DRUG), 0.9% Sodium Chloride 2000 mL bolus (DRUG).
Who is sponsoring clinical trial NCT01411852?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.